Skip to main content
Premium Trial:

Request an Annual Quote

Movers & Shakers: Feb 12, 2010

Premium

John Fjeldsted was appointed general manager of Agilent Technologies’ LC/MS business, the company said this week.

George Stafford also joined the company as LC/MS hardware R&D manager.

Fjeldsted will be responsible for managing the LC/MS business and driving market share in high-end LC/MS, Agilent said in a statement. Fjeldsted has been with the firm for more than 25 years and was previously R&D manager for the LC/MS unit as Agilent entered the LC/MS business with triple quadrupole and Q-TOF mass spectrometers.

Stafford was most recently R&D program manager for Thermo Fisher Scientific’s LC/MS research programs and university collaborations.


In vitro diagnostic firm Banyan Biomarkers announced this week the appointment of Jackson Streeter as its CEO and chief medical officer.

Streeter was most recently the chief scientific officer at medical device firm PhotoThera, which he also founded.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.